(Reuters) - Pharmasset Inc said it started a late-stage trial of its experimental hepatitis C drug, sending the pharmaceutical company's shares up as much as 12 percent. The study will seek to ascertain whether the drug, PSI-7977, taken orally along ... Pharmasset starts late-stage trial of hep C drug
Monday, October 31, 2011
Pharmasset starts late-stage trial of hep C drug
(Reuters) - Pharmasset Inc said it started a late-stage trial of its experimental hepatitis C drug, sending the pharmaceutical company's shares up as much as 12 percent. The study will seek to ascertain whether the drug, PSI-7977, taken orally along ... Pharmasset starts late-stage trial of hep C drug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment